Health Scan: Cellular activity and diseases

Neurodegenerative conditions result from an impairment of motor function or cognitive function or both.

January 13, 2013 00:30
2 minute read.
A PHOTOGRAPH of cells.

Photograph of cells 370. (photo credit: (Hebrew University)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


A new understanding of what happens on the cellular level during the development of neurodegenerative diseases – such as Parkinson’s, Alzheimer’s, amyotrophic lateral sclerosis (ALS) and Huntington’s diseases – offers promise toward possible new strategies for combating such diseases, according Hebrew University researchers. Neurodegenerative conditions result from an impairment of motor function or cognitive function or both. The impairment results from degeneration in the particular area of the brain responsible for those functions.

Although these diseases have been functionally linked to toxic protein deposits, there is much that is unknown about the mechanism through which aggregation causes toxicity and death at the cellular level. Inclusion bodies – structures comprised of pathogenic protein aggregates – have long been seen as a hallmark of disease, but the relationship between inclusions and disease has remained somewhat mysterious.

In a study published in PNAS (Proceedings of the [US] National Academy of Sciences), the Jerusalem researchers – working in the lab of Dr. Daniel Kaganovich in the cell and developmental biology department – present evidence suggesting that these inclusion bodies, which have traditionally been thought to accompany disease onset, actually have a cellbiological function that is not necessarily related to the disease conditions.

Further, the researchers suggest that some of those inclusion bodies are not only not toxic, but actually are part of a natural protective process. The researchers have identified two inclusion bodies, which they call JUNQ and IPOD.

Aggregation in the JUNQ can lead to toxicity, whereas aggregation in the IPOD is protective.

These findings, say the HU researchers, point to a new potential strategy for designing therapeutics for neurodegenerative disease. Instead of preventing proteins from aggregating, which can be very difficult, it may be possible to enhance the cellular ability to actively enclose harmful aggregates within protective inclusions, thereby neutralizing the toxic proteins that bring on further neurodegenerative damage and even death.


During Hanukka, Bar-Ilan University’s School of Medicine in the Galilee opened a “teddy bear hospital” designed to reduce anxiety about health care among young children. Some 150 preschoolers living in Safed, accompanied by their teddy bears and dolls, parents and older siblings, took part in the educational event, whose goal was to reduce stress related to medical care in general and hospitals in particular.

A virtual hospital with a variety of stations – including an emergency room, a reception area, operating rooms and an x-ray unit – created the atmosphere of a real-life medical facility within the School of Medicine complex. Through simulation, the teddy bears and dolls received the appropriate “treatment” according to the health problem defined by the children in their “admission forms.” Medical students acted as doctors – explaining procedures to the children, helping them care for the “patients” and answering their questions.

At the makeshift pharmacy, the children received “medicine” (sweet, tasty and healthy candy) and other surprises. Medical clowns entertained the children and helped reduce anxiety. Children’s songs served as background music and colorful lighting added to the happy atmosphere.

The teddy bear hospital, initiated by medical students with the cooperation of the medical school’s administration, demonstrated the new faculty’s commitment to strengthening the northern region of Israel through community involvement.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice


Cookie Settings